Speaker illustration

Doctor Tristan Maurer

Cambridge, Ma (United States of America)

Member of:

European Society of Cardiology

Tristan Maurer is Vice President of Scientific Research at Pfizer Inc (Cambridge, MA) where he is a member of the Medicine Design leadership team and head of Translational Modeling and Simulation (M&S). His team employs a range of M&S techniques (machine learning, physiologically-based pharmacokinetics, pharmacokinetic/pharmacodynamic modeling, and quantitative systems pharmacology) in support of drug design and early clinical development decisions. He has personally developed mathematical models in support of numerous clinical candidates and coauthored over 70 peer-reviewed original research manuscripts on the application of translational modeling in pharmaceutical research and development. Before joining Pfizer in 1999, Tristan earned a PharmD from the University of Georgia in 1993 and a PhD in Pharmaceutics from the University at Buffalo, State University of New York in 1999.

Relationship of tafamidis binding site occupancy, transthyretin stabilization, and disease modification in tafamidis treated transthyretin amyloid cardiomyopathy patients

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Chronic heart failure - Amyloidosis

Thumbnail

This platform is supported by

logo Novo Nordisk